SGHT - NASDAQ

Sight Sciences, Inc.

SGHT·NASDAQ

$4.55

+4.8%

HealthcareMedical - Devices

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$247.57M

EPS-0.7400

P/E Ratio-6.15

Earnings Date08/06/2026

sght

Income Before Tax

Last Annual Value

-38.42M

3-Year CAGR

24%

5-Year CAGR

-2%

10-Year CAGR

-10%

Adjust for Inflation

Sight Sciences, Inc. Competitors Analysis of Income Before Tax

SGHT · NASDAQ

Company	Income Before Tax	CAGR 3Y	CAGR 5Y	CAGR 10Y
Sight Sciences, Inc. NASDAQ:SGHT	-38.42M	N/A	N/A	N/A
Owens & Minor, Inc. NYSE:OMI	-357.36M	N/A	N/A	N/A
Forte Biosciences, Inc. NASDAQ:FBRX	-68.34M	N/A	N/A	N/A
Hyperfine, Inc. NASDAQ:HYPR	-35.57M	N/A	N/A	N/A
MaxCyte, Inc. NASDAQ:MXCT	-44.63M	N/A	N/A	N/A
Owlet, Inc. NYSE:OWLT	-39.70M	N/A	N/A	N/A
Rapid Micro Biosystems, Inc. NASDAQ:RPID	-47.08M	N/A	N/A	N/A
TriSalus Life Sciences, Inc. NASDAQ:TLSI	-39.22M	N/A	N/A	N/A
908 Devices Inc. NASDAQ:MASS	-33.34M	N/A	N/A	N/A
Senseonics Holdings, Inc. NASDAQ:SENS	-69.11M	N/A	N/A	N/A
Viemed Healthcare, Inc. NASDAQ:VMD	21.77M	14.8%	11.7%	69.8%

Sight Sciences, Inc. Fair Value Envelope

SGHT · NASDAQ

Our analysis suggests that SGHT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.55, this represents a potential HIDDEN relative to our calculated worth for Sight Sciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $4.55

Related Guides

Blog Categories

Continue your SGHT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.